Mein Warenkorb

IL-13RA2

IL-13RA2 Produktliste

  • Attribut

    Kits (1)

  • Produktbibliothek

    Online (1)

  • Spezies

    Human (1)

  • Etikett

    - (1)

  • Marker

    - (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
EP-149
Human
-
IL-13RA2 [Biotinylated] : IL-13 Inhibitor Screening ELISA Kit In den Warenkorb legen
Gesamtmenge1
  • 1

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Girentuximab-Zr-89TLX-250-CDx; 89Zr-TX-250; TLX250-CDx; 89Zr-TX250Phase 3 ClinicalUrinary Bladder Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Cholangiocarcinoma; Sarcoma; Nasopharyngeal Carcinoma; Contrast agents; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms
Details
Lutetium-177 DOTA girentuximabTLX-250Phase 2 ClinicalHeidelberg, Telix Pharmaceuticals LtdSolid tumours; Carcinoma, Renal Cell; Neoplasms
Details
[177Lu]Lu-DPI-4452[177Lu]Lu-DPI-4452Phase 2 ClinicalDebiopharm International SaCarcinoma, Renal Cell; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal
Details
Debio-0328[68Ga]Ga-DPI-4452; Gallium-68-DPI-4452Phase 2 ClinicalDebiopharm International SaCarcinoma, Renal Cell; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal
Details
PMI-05PMI-05Phase 1 ClinicalPrecision Molecular IncNeoplasms
Details
Girentuximab MAb-G250; cG250; WX-G250Phase 1 ClinicalKidney Neoplasms; Carcinoma, Renal Cell
Details
PHC-102PHC102; 99mTc-CAIXPhase 1 ClinicalPhilochemCarcinoma, Renal Cell
Details
Indium-111-DOTA-girentuximab-IRDye800CW (Radboud University)Phase 1 ClinicalRadboud University NijmegenCarcinoma, Renal Cell; Diagnostic agents
Details
CA9hu-1CA9hu-1Phase 1 ClinicalMabpro ASHead and Neck Neoplasms; Carcinoma, Renal Cell; Triple Negative Breast Neoplasms; Mesothelioma; Carcinoma, Non-Small-Cell Lung
Details
Sulfamide-nitroimidazoleClinicalDualtpharmaNeoplasms
Details
PD-32766PD-32766; 64Cu-PD-32766; 225Ac-PD-32766ClinicalPeptiDream IncOvarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Glioblastoma; Triple Negative Breast Neoplasms; Colorectal Neoplasms
Details
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns